Project Grant CLSS00000061216

This $125,000 annual Project Grant award from the National Center for Injury Prevention and Control, under the Drug-Free Communities (DFC) Support Program (CFDA 93.276), supports the Opioid Prescription Drug and Synthetics (O.P.P.S.) Coalition led by Healing In The Hood Inc., a minority-owned non-profit organization in Blytheville, Arkansas. The funding enables the coalition to implement comprehensive, evidence-based strategies to reduce youth (ages 12-18) use of marijuana and misuse of...

The federal Project Grant award with ID DP2DA062283 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $2,542,500 grant, awarded on September 1, 2024, will support the development of novel econometric methods and a unified framework for integrating real-world evidence (RWE) to analyze inconclusive randomized controlled trials (RCTs) focused on opioid use disorder (OUD) treatments. The project, to be conducted by Weill...

The National Institute on Drug Abuse (NIDA) awarded a $220,668 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Amalgent Therapeutics, Inc. in Greenville, NC. This grant supports the development of a novel opioid adjuvant technology that aims to enhance the pain-relieving efficacy of opioid medications while mitigating risks such as abuse potential, tolerance, and neuropathic pain. The project has two key objectives: 1) investigating the mechanism by which the...

The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $267,000 Project Grant (R21DA058120) to The Children's Hospital Corporation (Boston Children's Hospital) to develop depot formulations for on-demand, tamper- and diversion-proof delivery of opioids. The goal is to create injectable polymer-based depot formulations that are covalently bonded to opioids via photolabile linkers, which would make the formulations resistant to...

The State of Alaska Department of Health (DOH) was awarded a $23,966,144 Project Grant under the Substance Abuse and Mental Health Services Administration's (SAMHSA) Opioid State Targeted Response (Opioid STR) program (CFDA 93.788). The grant will fund a comprehensive approach to address the opioid crisis in Alaska through prevention, harm reduction, treatment, and recovery services over a project period from September 30, 2024 to September 29, 2027. Key initiatives include sustaining the...

The Louisiana Department of Health (LDH), through its Office of Behavioral Health (OBH) Division, has been awarded a $54,004,380 Project Grant by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Opioid STR Federal Grant Program (CFDA 93.788). The Louisiana State Opioid Response (LASOR) 4.0 program will enhance existing statewide prevention, treatment, and recovery support services for individuals with or at risk for opioid use disorder (OUD) and/or stimulant use...

This Project Grant award, funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243), provides $182,536 to the Confederated Tribes of Grand Ronde in Oregon. The goal of the project is to decrease opioid use and prevent fatal and non-fatal opioid overdoses within the tribal community by implementing evidence-based programs, medication-assisted treatment...

The Doya Natsu Healing Center (DNHC) of the Eastern Shoshone Tribe was awarded a $591,268 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program administered by the Substance Abuse and Mental Health Services Administration (SAMHSA). The grant will fund a 5-year Tribal Opioid Response (TOR4) project to increase access to culturally-driven, evidence-based services for treating opioid use disorder (OUD) and substance...

The Department of Justice, Office of Justice Programs, Bureau of Justice Assistance awarded a $1,600,000 Comprehensive Opioid, Stimulant, and other Substances Use Program (CFDA 16.838) Project Grant to the Southern Nevada Health District (SNHD) and sub-recipients Las Vegas Metropolitan Police Department (LVMPD) and University of Nevada, Las Vegas (UNLV). The grant will fund a collaborative initiative to address the opioid crisis in Clark County, Nevada through a public health-focused overdose...

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), is intended to investigate whether a pharmacist-integrated model of opioid use disorder (OUD) treatment can increase naloxone co-prescribing in primary care. The $193,336 award to Trustees of Dartmouth College will fund a research project with three aims: (1) describing federal, state, and clinic-level policies and OUD interventions impacting...